Comparison among two drugs commonly used in the prevention and treatment of thrombosis, to prevent thromboembolism after total cavopulmonary operation.
Not Applicable
- Conditions
- Q22.6Hypoplastic right heart syndrome, thrombosis, Tricuspid atresia.C14.907.355.830C14.240.400.920
- Registration Number
- RBR-4z9wdg
- Lead Sponsor
- Hospital do Coração da Associação do Sanatório Sirio
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- recruitment completed
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Scheduling total cavopulmonary operation according to the clinical criteria for surgery.
Parents or guardians agree to the inclusion in the study.
Exclusion Criteria
Patients with contraindications to receive any of the medications (sodium warfarin or aspirin)
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Absence of thrombosis inside of the extra-cardíac conduit, diagnosed by transesophageal echocardiography: analyzed by one examiner to assess the absence of thrombus imaging in light of extra-cardiac conduit.<br>Absence of thrombosis inside of the extra-cardíac conduit diagnosed by CT angiography: acquisition with only carried out by one examiner with contrast, evaluating the absence of thrombus in the lumen or adhered to the wall of the extra-cardíac conduit.
- Secondary Outcome Measures
Name Time Method Absence of subclinical thromboembolism diagnosed by scintigraphy ventilation-perfusion, assessed by one examiner. The interpretation criteria follow the standardization scheme Nuclear Medicine Service of the Heart Hospital of Syrian Sanatorium Association, according to guidelines established by prospective investigation of pulmonary embolism diagnosis (PIOPED)